NCT06963541View on ClinicalTrials.gov

IL-40 and IL-41 Levels in Sepsis, Septic Shock, and Healthy Individuals

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
SepsisSeptic ShockInflammationBiomarkers
Interventions
OTHER

No intervention; Observational study

No interventions are associated with either group. This is an observational study without experimental procedures.

Trial Locations (1)

630000

Harran University Faculty of Medicine, Department of Anesthesiology and Reanimation, Sanliurfa

All Listed Sponsors
lead

Melahat Yalcin Solak

OTHER

NCT06963541 - IL-40 and IL-41 Levels in Sepsis, Septic Shock, and Healthy Individuals | Biotech Hunter | Biotech Hunter